about
Therapeutic strategies targeting cancer stem cellsThe role of CD95 and CD95 ligand in cancerThe BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cellsErbB2 and p38γ MAPK mediate alcohol-induced increase in breast cancer stem cells and metastasisChronic ethanol exposure enhances the aggressiveness of breast cancer: the role of p38γDocosahexaenoic acid and disulfiram act in concert to kill cancer cells: a mutual enhancement of their anticancer actionsRetinoid signaling regulates breast cancer stem cell differentiation.Small interfering RNA library screen identified polo-like kinase-1 (PLK1) as a potential therapeutic target for breast cancer that uniquely eliminates tumor-initiating cells.CD133-positive cancer stem cells from Colo205 human colon adenocarcinoma cell line show resistance to chemotherapy and display a specific metabolomic profile.ABCG2, a novel antigen to sort luminal progenitors of BRCA1- breast cancer cells.Essential role of the cancer stem/progenitor cell marker nucleostemin for indole-3-carbinol anti-proliferative responsiveness in human breast cancer cells.Molecular characterisation of cell line models for triple-negative breast cancers.HSF1 regulation of β-catenin in mammary cancer cells through control of HuR/elavL1 expression.Modification of topoisomerases in mammospheres derived from breast cancer cell line: clinical implications for combined treatments with tyrosine kinase inhibitors.Upregulation of VEGF-A and CD24 gene expression by the tGLI1 transcription factor contributes to the aggressive behavior of breast cancer cells.Nanoparticle-based delivery of siDCAMKL-1 increases microRNA-144 and inhibits colorectal cancer tumor growth via a Notch-1 dependent mechanism.Canonical and non-canonical NF-κB signaling promotes breast cancer tumor-initiating cellsBioengineering embryonic stem cell microenvironments for the study of breast cancerMetformin kills and radiosensitizes cancer cells and preferentially kills cancer stem cellsCXCR4 activation maintains a stem cell population in tamoxifen-resistant breast cancer cells through AhR signallingCoexistence of benign phyllodes tumor and invasive ductal carcinoma in distinct breasts: case report.CD44+/CD24- phenotype contributes to malignant relapse following surgical resection and chemotherapy in patients with invasive ductal carcinoma.Multispecies model of cell lineages and feedback control in solid tumors.Estradiol, TGF-β1 and hypoxia promote breast cancer stemness and EMT-mediated breast cancer migrationDrug Resistant Breast Cancer Cell Line Displays Cancer Stem Cell Phenotype and Responds Sensitively to Epigenetic Drug SAHA.miR-612 suppresses the invasive-metastatic cascade in hepatocellular carcinoma.Cancer stem cells and therapeutic targets: an emerging field for cancer treatmentMetalloproteinase-disintegrin ADAM12 is associated with a breast tumor-initiating cell phenotype.Keeping an open mind: highlights and controversies of the breast cancer stem cell theoryAssociation of PTP1B with Outcomes of Breast Cancer Patients Who Underwent Neoadjuvant Chemotherapy.The GLI1 splice variant TGLI1 promotes glioblastoma angiogenesis and growth.A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers.Targeting tumour-initiating cells to improve the cure rates for triple-negative breast cancer.Immunotherapy of prostate cancer: should we be targeting stem cells and EMT?Functionalized nanostructures with application in regenerative medicine.MicroRNAs regulate both epithelial-to-mesenchymal transition and cancer stem cells.Cellular and molecular chaperone fusion vaccines: targeting resistant cancer cell populations.Clinical translation for endometrial cancer stem cells hypothesis.Standardized Extract from Caesalpinia spinosa is Cytotoxic Over Cancer Stem Cells and Enhance Anticancer Activity of Doxorubicin.CAF cellular glycolysis: linking cancer cells with the microenvironment.
P2860
Q26781398-DE6C79F0-CE8E-47FD-8B1D-55E551159614Q26995847-FCDC0203-B421-4415-A568-D86B9BB22328Q27340125-21D982BF-D14D-41D8-8FD0-7832AE33848CQ28384120-44550963-80FB-4AC4-A7A3-996B70F7E081Q28391509-AB1F524F-E3C5-487F-8788-78342354A600Q33566735-E32ABD0C-E39C-4F72-A3FC-81C9B0B0767EQ33817989-DDF854A3-9F13-43AB-A220-21FB98FF0869Q34152071-1ECEE34C-1E1A-4B49-9AEA-011794DA6E1FQ34170564-ADF4FD2B-AD81-455D-A044-00063AEAC6C2Q34252280-A34AF5C9-4E73-41AF-BC37-4B158CE3EE8BQ34270803-42EE394A-4871-455C-9D3B-710B8A68C7B5Q34476551-2B1CB59A-E83B-4D84-9C74-5C38EAACDA88Q34765945-522C7B84-7794-4FAF-8581-401715BEA333Q34896154-36856005-2F6E-4F87-8060-FF8DAA1A295DQ35219125-5246B16F-F8A6-4DAB-92EA-70F570D66E92Q35439618-D934CE56-0D5E-4C85-A339-6730877349DEQ35586803-B64D228F-E14B-4AF4-8B04-577137BF56DBQ35600151-E3CCD963-25DE-46A9-B981-9C322046968AQ35884622-EAA6F18E-99FE-407F-8E42-F91F3769D3E0Q36075168-42646132-3E8D-4ECF-9085-1E45CAAFE4A0Q36167858-64924BD6-ACAA-4024-A698-6C675A45A1C2Q36202984-E62BA014-4440-4E4A-AF9C-29714EA151CDQ36216894-06AD3076-9815-4FD8-BC56-78E9781AB9F2Q36640378-F85C8E0A-60D4-420D-B9A7-E8FA539A14C9Q36717485-5F6B2DAE-B9C7-4FCC-882E-3F83FF38A3FDQ36750072-0A061D92-50E8-4E55-A0BB-C2383EBCCECCQ37200395-222D7CF4-C717-4997-BC6B-719343350FEAQ37352137-C8FB2262-B6A5-4A88-9BF0-AF4CA83A604EQ37356270-5C95AA76-D17F-45B5-91D5-35EDFED6BE85Q37397626-2AF1811A-6717-44AE-8DAC-ADE42F74A859Q37417201-122CFD73-22ED-45F4-8700-6046888CAE00Q37694661-E1D8C8EE-D3A5-4AB8-A3E3-50C50776975FQ37775105-1FC5F061-9D6D-4CEA-AB66-B9395E8C2EA5Q37891875-6D9AF8A7-F68E-4CB5-9EA0-C736D2ADF8BAQ38001430-371FECE0-2DB5-4FCB-A4A7-680D5D824076Q38086010-86DB56DB-004D-4B47-84B4-DF0E43181179Q38107522-FB0CBCB4-600E-41CE-92E1-180F0214E785Q38557171-C9E2F499-2240-4D55-9CCB-5E4C79C2B7FCQ38730830-A2B6A9EA-9E26-45DD-AAAB-94F15F4CA31DQ38807630-D4FA7395-5E64-4E84-B7AF-E65B59DE79EF
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Breast cancer stem cells: tools and models to rely on.
@ast
Breast cancer stem cells: tools and models to rely on.
@en
type
label
Breast cancer stem cells: tools and models to rely on.
@ast
Breast cancer stem cells: tools and models to rely on.
@en
prefLabel
Breast cancer stem cells: tools and models to rely on.
@ast
Breast cancer stem cells: tools and models to rely on.
@en
P2860
P921
P356
P1433
P1476
Breast cancer stem cells: tools and models to rely on.
@en
P2093
Daniel Birnbaum
P2860
P2888
P356
10.1186/1471-2407-9-202
P407
P5008
P577
2009-06-25T00:00:00Z
P5875
P6179
1018034361